NanoViricides Inc. (NNVC)

[weedhopper]

FANTASTIC NEWS !!!!!!!!!!!!!!!!!!!!!!

Our team of Doc's are workin workin workin to get our Cides where they need to be. I liked this part it shows there will be many different strengths and ways to use it !!!!!!

The Company is planning on two separate
indications for NV-INF-1: High strength dosage form for hospitalized patients
with severe influenza, and a single course therapy for the out-patients with
less severe influenza.


And this part is GREAT TOO !!!!!

This clinical drug candidate is expected to be effective against a majority of
strains and types of influenzas including novel epidemic influenza strains such
as the one encountered in 2009-2010 (so called "swine flu"); seasonal flu such
as H1N1, H3N2; highly pathogenic types such as H7N and H9N; as well as the
highly lethal type, so called "bird flu" or H5N1. All influenza viruses use the
same common receptor to bind to human cells. Therefore the Company believes that
its influenza drug candidate should work against most of the influenza viruses.

GOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOO NNVC !!!
Weedie